Macrophage‐specific FGF12 promotes liver fibrosis progression in mice
Hepatology · 2023
DOI: 10.1002/hep.32640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology, 2023. Verfasst von Santie Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health) , School of Pharmaceutical Science , Wenzhou Medical University …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background and Aims: Chronic liver diseases are associated with the development of liver fibrosis. Without treatment, liver fibrosis commonly leads to cirrhosis and HCC. FGF12 is an intracrine factor belonging to the FGF superfamily, but its role in liver homeostasis is largely unknown. This study aimed to investigate the role of FGF12 in the regulation of liver fibrosis. Approach and Results: FGF12 was up‐regulated in bile duct ligation (BDL)–induced and CCL 4 ‐induced liver fibrosis mouse models. Expression of FGF12 was specifically up‐regulated in nonparenchymal liver cells, especially in hepatic macrophages. By constructing myeloid‐specific FGF12 knockout mice, we found that deletion of FGF12 in macrophages protected against BDL‐induced and CCL 4 ‐induced liver fibrosis. Further results revealed that FGF12 deletion dramatically decreased the population of lymphocyte antigen 6 complex locus C high macrophages in mouse fibrotic liver tissue and reduced the expression of proinflammatory cytokines and chemokines. Meanwhile, loss‐of‐function and gain‐of‐function approaches revealed that FGF12 promoted the proinflammatory activation of macrophages, thus inducing HSC activation mainly through the monocyte chemoattractant protein‐1/chemokine (C–C motif) receptor 2 axis. Further experiments indicated that the regulation of macrophage activation by FGF12 was mainly mediated through the Janus kinase–signal transducer of activators of transcription pathway. Finally, the results revealed that FGF12 expression correlates with the severity of fibrosis across the spectrum of fibrogenesis in human liver samples. Conclusions: FGF12 promotes liver fibrosis progression. Therapeutic approaches to inhibit macrophage FGF12 may be used to combat liver fibrosis in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health) , School of Pharmaceutical Science , Wenzhou Medical University , Wenzhou , People's Republic of China.
- College of Pharmacy and Research Institute of Drug Development , Chonnam National University , Gwangju , Republic of Korea.
- Department of Hepatobiliary Surgery , The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University , Wenzhou , People's Republic of China.
- Central Laboratory , The First Affiliated Hospital of Wenzhou Medical University , Wenzhou , People's Republic of China.
- Haihe Laboratory of Cell Ecosystem , School of Pharmaceutical Science , Wenzhou Medical University , Wenzhou , People's Republic of China.
Zitieren
APA
Li, S., Zhou, B., Xue, M., Zhu, J., Tong, G., Fan, J., Zhu, K., Hu, Z., Chen, R., Dong, Y., Chen, Y., Lee, K. Y., Li, X., Jin, L., & Cong, W. (2023). Macrophage‐specific FGF12 promotes liver fibrosis progression in mice. Hepatology. https://doi.org/10.1002/hep.32640
Vancouver
Li S, Zhou B, Xue M, Zhu J, Tong G, Fan J, et al. Macrophage‐specific FGF12 promotes liver fibrosis progression in mice. Hepatology. 2023. doi:10.1002/hep.32640
BibTeX
@article{Li2023,
author = {Li, Santie and Zhou, Bin and Xue, Mei and Zhu, Junjie and Tong, Gaozan and Fan, Junfu and Zhu, Kunxuan and Hu, Zijing and Chen, Rui and Dong, Yonggan and Chen, Yiming and Lee, Kwang Youl and Li, Xiaokun and Jin, Litai and Cong, Weitao},
title = {Macrophage‐specific FGF12 promotes liver fibrosis progression in mice},
journal = {Hepatology},
year = {2023},
doi = {10.1002/hep.32640}
}
EUVIMED